US FDA approves first HLH treatment in 24 years  BioPharma-Reporter.com

Sobi’s Gamifant is approved as a treatment for pediatric and adult patients with primary hemophagocytic lymphohistiocytosis. Gamifant (emapalumab-lzsg) is an …